HEPCVIR L SOFOSBUVIR LEDIPASVIR TABLETS

Get a Price/Quote

HEPCVIR L SOFOSBUVIR LEDIPASVIR TABLETS Specification

Origin of Medicine
India

Pacakaging (Quantity Per Box)
28 tablets per box

Dosage Form
Solid/Tablet

Indication
Treatment of Hepatitis C Virus (HCV) infection

Salt Composition
Sofosbuvir and Ledipasvir

Drug Type
Allopathic

Ingredients
Sofosbuvir 400mg and Ledipasvir 90mg

Physical Form
Tablets

Function
Antiviral medication

Recommended For
Chronic Hepatitis C Infection

Dosage
As prescribed by the physician

Dosage Guidelines
Take orally, exactly as directed by your doctor

Suitable For
Adults

Quantity
28 tablets

Storage Instructions
Store below 30C, protect from light and moisture

HEPCVIR L SOFOSBUVIR LEDIPASVIR TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About HEPCVIR L SOFOSBUVIR LEDIPASVIR TABLETS

Hepcvir L Sofosbuvir & Ledipasvir

Specifications:

Brand Name : Hepcvir L
Content: Sofosbuvir and Ledipasvir
Strength: Sofosbuvir 400 mg & Ledipasvir 90 mg
Packing: 1X28 Tablets
Type: Tablets
Uses: Hepatitis C
Manufactured By : Cipla

NOTE:- Hepcvir LIs A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...............

Potent Antiviral Action

HEPCVIR L is formulated with Sofosbuvir and Ledipasvir, two highly effective agents targeting Hepatitis C Virus. Together, they work to inhibit viral replication in the body, aiding in the elimination of the infection. This combination has become a cornerstone therapy for chronic HCV, offering patients a reliable pathway to recovery.

Optimal Dosage and Administration

Available as solid tablets, HEPCVIR L should be administered orally as directed by your healthcare provider. The exact dosage and duration depend on individual patient needs. It is vital to adhere to the prescribed regimen without interruption for maximum therapeutic outcome.

Safe Storage and Handling

To ensure product integrity, HEPCVIR L tablets must be stored below 30C and protected from light and moisture. Always keep the medication in its original bottle, out of reach of children, and follow disposal guidelines as per your pharmacists advice.

FAQs of HEPCVIR L SOFOSBUVIR LEDIPASVIR TABLETS:

Q: How should I take HEPCVIR L tablets for Hepatitis C?

A: Take HEPCVIR L tablets orally, exactly as prescribed by your doctor. Do not alter the dosage or frequency. Swallow the tablet whole with water at the same time each day for the duration advised by your healthcare provider.

Q: What are the main benefits of using HEPCVIR L for Hepatitis C treatment?

A: HEPCVIR L provides a highly effective and convenient oral therapy for chronic Hepatitis C infection. Its combination of Sofosbuvir and Ledipasvir helps inhibit viral replication, significantly increasing the chance of viral clearance and long-term improvement of liver health.

Q: When should I start a new course of HEPCVIR L?

A: Begin treatment with HEPCVIR L only after receiving a prescription and diagnosis from your healthcare provider. The course duration is determined by your specific HCV genotype and medical profile. Do not self-medicate or restart therapy without medical supervision.

Q: Where should HEPCVIR L tablets be stored for best results?

A: Store HEPCVIR L tablets below 30C, away from light and moisture, in their original bottle. Avoid bathroom cabinets or places with high humidity, and ensure the medication is out of reach of children.

Q: What process is involved in obtaining HEPCVIR L?

A: HEPCVIR L is a prescription medication. Consult your physician for diagnosis and prescription. Once prescribed, it can be obtained from licensed distributors, exporters, or pharmacies supplying Cipla products.

Q: Is HEPCVIR L suitable for all adults with Hepatitis C?

A: HEPCVIR L is indicated for adults with chronic Hepatitis C virus infection. However, its suitability depends on individual factors such as liver function, HCV genotype, and potential drug interactions. Your physician will assess eligibility before starting therapy.

Tell us about your requirement